Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost.
第一作者:
P,Angeli
第一单位:
Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy. pangeli@unipd.it
作者:
主题词
投药, 口服(Administration, Oral);白蛋白类(Albumins);抗菌药(Anti-Bacterial Agents);抗高血压药(Antihypertensive Agents);头孢他啶(Ceftazidime);环丙沙星(Ciprofloxacin);女(雌)性(Female);卫生保健费用(Health Care Costs);肝肾综合征(Hepatorenal Syndrome);人类(Humans);输注, 静脉内(Infusions, Intravenous);住院时间(Length of Stay);肝硬化(Liver Cirrhosis);赖氨酸加压素(Lypressin);男(雄)性(Male);中年人(Middle Aged);腹膜炎(Peritonitis)
DOI
10.1111/j.1365-2036.2006.02706.x
PMID
16393283
发布时间
2018-12-03
- 浏览51
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文